The Patent Finder

89BIO, Inc.

9 patents currently held · Updated Nov 21, 2026
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Jun 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 10, 2027
    The maintenance fee for Mutant FGF-21 peptide pegylated conjugates and uses thereof (US 10,407,479) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
  • 2 fees due Jun 1 to 26, 2027 · next Jun 1

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,200,049Remodeling and Glycopegylation of Fibroblast Growth Factor (FGF)
In force
 · Medium confidence
In forceMedium confidence
US 10,874,714A Method of Treating of Fibroblast Growth Factor 21 (FGF-21) Deficiency
In force
 · Medium confidence
In forceMedium confidence
US 10,407,479Mutant FGF-21 peptide pegylated conjugates and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 12,037,376Methods of treatment using mutant FGF-21 peptide conjugates
In force
 · USPTO record
In forceUSPTO record
US 11,427,623Methods of treatment using mutant FGF-21 peptide conjugates
In force
 · USPTO record
In forceUSPTO record
US 11,596,669Liquid Formulations Comprising Mutant FGF-21 Peptide Pegylated Conjugates
In force
 · High confidence
In forceHigh confidence
US 11,850,275Liquid Formulations Comprising Mutant FGF-21 Peptide Pegylated Conjugates
In force
 · High confidence
In forceHigh confidence
US 12,350,314Liquid Formulations Comprising Mutant FGF-21 Peptide Pegylated Conjugates
In force
 · High confidence
In forceHigh confidence
US 12,036,284Compositions and Methods of Treatment for Severe Hypertriglyceridemia
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 10 patents in force now held by others · 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 4 no status recorded

Showing 1 to 10 of 11, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/226,706Liquid Formulations Comprising Mutant FGF-21 Peptide Pegylated ConjugatesJun 3, 2025Pending
19/086,868Mutant FGF-21 Peptide Pegylated Conjugates and Uses ThereofMar 21, 2025Pending
19/032,871Compositions and Methods of Treatment for Severe HypertriglyceridemiaJan 21, 2025Pending
19/018,376Methods of Treatment Using Mutant FGF-21 Peptide ConjugatesJan 13, 2025Pending
18/740,787Chemical Synthesis of CYTIDINE-5'-MONOPHOSPHO-N-GLYCYL-SIALIC AcidJun 12, 2024Pending
18/733,382Compositions and Methods of Treatment for Severe HypertriglyceridemiaJun 4, 2024Pending
18/326,510May 31, 2023No status recorded
17/332,062May 27, 2021No status recorded
17/793,953Methods for Promoting Weight LossJan 29, 2021Pending
17/075,011Oct 20, 2020No status recorded
10 of 11 applications shown.
Pro members see all 11 published applications.
Pro members: see all 11 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited